Candel Therapeutics's total assets for Q1 2025 were $95.91M, a decrease of -10.26% from the previous quarter. CADL total liabilities were $21.23M for the fiscal quarter, a -47.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.